Ark Invest, through its ARK Fintech Innovation ETF ARKF -5.46% + Free Alerts , bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s ...

Other Key Trades: Ark Invest sold 307,632 shares of Accolade Inc. from its ARKG ETF. The firm also reduced its holdings in Nu Holdings and Adyen NV from its ARK Next Generation Internet ETF ARKW ...

ARK Genomic Revolution ETF (BATS:ARKG – Get Free Report) was the target of some unusual options trading on Tuesday. Stock traders bought 32,950 call options on the company. This is an increase of ...

BEAM), split between ARK's Innovation ETF (ARKK) and ARKG, with a combined dollar value of $788,856. This investment continues a trend, as ARK has been consistently increasing its position in Beam ...

Star portfolio manager Cathie Wood’s Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb. 4 ...

Another notable transaction included the purchase of 23,555 shares of Beam Therapeutics Inc (NASDAQ:BEAM), split between ARK's Innovation ETF (ARKK) and ARKG, with a combined dollar value of $788,856.

In a move that caught the attention of investors, ARK significantly increased its holdings in Beam Therapeutics Inc (NASDAQ:BEAM), purchasing a total of 170,778 shares valued at approximately $5.82 ...

ARK significantly increased its holdings in Beam Therapeutics Inc (NASDAQ:BEAM), purchasing a total of 170,778 shares valued at approximately $5.82 million across its ARKK and ARKG funds.

Don’t look now, but Cathie Wood of Ark Invest is fresh off an ... In any case, here are three intriguing holdings within the ARK Genomic Revolution ETF (ARKG), a thematic Ark ETF that’s ...